Online: | |
Visits: | |
Stories: |
ReportsnReports adds Peanut Allergy market research to its database.
This report provides comprehensive information on the therapeutic development for Peanut Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Peanut Allergy and special features on late-stage and discontinued projects.
Get discount on this research at http://www.reportsnreports.com/contacts/Discount.aspx?name=453515 .
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Complete research is available at http://www.reportsnreports.com/reports/453515-peanut-allergy-pipeline-review-h2-2015.html .
Scope
Reasons to buy
List of Tables
Number of Products under Development for Peanut Allergy, H2 2015 8
Number of Products under Development for Peanut Allergy – Comparative Analysis, H2 2015 9
Number of Products under Development by Companies, H2 2015 10
Number of Products under Investigation by Universities/Institutes, H2 2015 11
Comparative Analysis by Clinical Stage Development, H2 2015 12
Comparative Analysis by Early Stage Development, H2 2015 13
Comparative Analysis by Unknown Stage Development, H2 2015 14
Products under Development by Companies, H2 2015 15
Products under Investigation by Universities/Institutes, H2 2015 16
Peanut Allergy – Pipeline by BioLingus AG, H2 2015 17
Peanut Allergy – Pipeline by BioTech Tools s.a., H2 2015 18
Peanut Allergy – Pipeline by DBV Technologies S.A., H2 2015 19
Peanut Allergy – Pipeline by HAL Allergy BV, H2 2015 20
Peanut Allergy – Pipeline by Immunomic Therapeutics, Inc., H2 2015 21
Assessment by Monotherapy Products, H2 2015 22
Number of Products by Stage and Target, H2 2015 24
Number of Products by Stage and Mechanism of Action, H2 2015 26
Number of Products by Stage and Route of Administration, H2 2015 28
Number of Products by Stage and Molecule Type, H2 2015 30
Peanut Allergy Therapeutics – Recent Pipeline Updates, H2 2015 47
Peanut Allergy – Dormant Projects, H2 2015 53
Peanut Allergy – Discontinued Products, H2 2015 54